monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
Published 5 years ago • 975 plays • Length 10:15Download video MP4
Download video MP3
Similar videos
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
5:12
monaleesa-3: ribociclib plus fulvestrant in hr mbc
-
1:22
dr. slamon the phase iii results of monaleesa-3 trial in hr /her2- breast cancer
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole
-
6:44
cdk4/6 inhibitor ribociclib plus fulvestrant improves overall survival in postmenopausal hr-posi...
-
1:21
qol in monaleesa-2, 3, and 7
-
1:19
dr. slamon on os results of the monaleesa-3 trial in hr /her2- breast cancer
-
3:42
discussing the latest results from the monaleesa-3 study
-
6:44
overall survival (os) results of the phase iii monaleesa-3 trial
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
0:27
toxicities associated with ribociclib from monaleesa-3 trial
-
0:53
neelima denduluri, md, on the monaleesa-3 study in hr /her2- advanced breast cancer
-
2:49
safety and efficacy of ribociclib and letrozole in advanced breast cancer – the monaleesa-2 trial
-
1:38
sara m. tolaney, md, mph, discusses the fulvestrant ribociclib arm of the monaleesa-3 study
-
3:40
monaleesa-7: results from phase iii trial looking at ribociclib as an addition to endocrine ther...
-
13:54
overall survival results from monaleesa-2: endocrine therapy and ribociclib in hr positive and h...
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
2:55
practical implications of the monaleesa-3 trial
-
13:53
gs2-01: "overall survival subgroup analysis by metastatic site from the phase3 monaleesa-2..."